Akèy › Kansè vejik › North Carolina › Raleigh
Etid klinik pou Kansè vejik nan Raleigh, NC
4 etid pou Kansè vejik ap chèche patisipan nan sit nan ak bò kote Raleigh (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
Ap rekriteFaz 1/2
- Duke Cancer Center Raleigh, Raleigh
- Duke Raleigh Hospital, Raleigh
- Duke Women's Cancer Care Raleigh (Pharmacy location and location of CT, MRI and Bone scan machines), Raleigh
A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)
Ap rekriteFaz 3
- WakeMed Raleigh Campus ( Site 0811), Raleigh
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
Ap rekriteFaz 2
- Associated Urologist of North Carolina (Solaris), Raleigh
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
Ap rekriteFaz 1/2
- Associated Urologists of North Carolina, Raleigh
Etid Kansè vejik nan lòt vil
- New York City, NY35 etid
- Nashville, TN31 etid
- Houston, TX31 etid
- Dallas, TX27 etid
- Washington, DC26 etid
- Boston, MA26 etid
- Baltimore, MD24 etid
- Los Angeles, CA24 etid
- St. Louis, MO22 etid
- Seattle, WA21 etid
- Chicago, IL21 etid
- Philadelphia, PA21 etid
Lòt etid nan Raleigh
- Ensifizyans kadyak7 etid
- Maladi atè koronè6 etid
- Obèsite6 etid
- Dyabèt Tip 26 etid
- Degeneresans makile6 etid
- Ateroskleroz5 etid
- Sipwa5 etid
- Maladi kadyovaskilè5 etid
- Kansè Endomèt5 etid
- Akidan serebavaskilè5 etid
- Ensifizans renn4 etid
- Dyabèt4 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.